Nucleic Acid Testing Market : Global Market Estimation, Dynamics, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Nucleic Acid Testing Market: By Technique (Probe Amplification, Target Amplification, Signal Amplification), By Application (Cancer, Infectious Diseases, Genetics, Personalized Medicine), By End User (Hospitals, Diagnostic Centers, Research organizations, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Nucleic acid testing market size was valued at USD x billion in 2021, growing at a CAGR of x% during the forecast period 2022-2028. Nucleic acid testing market report gives a comprehensive outlook on nucleic acid testing across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, technology, application, end user, and region. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged.

Nucleic acid testing market is estimated to grow at significant CAGR over the forecast years 2022-2028 due to an increase in the prevalence of certain types of cancers and infectious diseases across the globe. For instance, according to WHO 2018 data, approximately 9.6 Mn death occurred due to cancer around the globe. Moreover, rise in R&D for the development of advanced technologies for nucleic acid testing, increased in demand for early stage disease diagnosis and personalized medicine, raise in funding from public and private sectors for the healthcare infrastructure development, and surge in demand for nucleic acid testing from blood banks are anticipated to boost the market over the forecast timeframe. However, stringent regulatory guidelines, high cost and complexity in the testing, and lack of skilled professionals and sophisticated healthcare infrastructure in underdeveloped countries are hinder the growth of market in future years.

Nucleic Acid Testing Market

MARKET SUMMARY
-
X
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR–X%
  • Largest Market– North America
  • Fastest Market- Europe

Nucleic Acid Testing Market Analysis

  • Nucleic acid testing market expanding at a significant CAGR over 2022 to 2028 owing to increase in the prevalence of cancer disease.
  • Based on technology type, polymerase chain reaction accounted for a larger market revenue share in 2018 and is projected to gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global nucleic acid testing market
  • For instance, in July 2018, Abbott launched point-of-care nucleic acid test m-PIMA HIV-1/2 VL in the Netherlands for quick, accurate and easy management of HIV infection.
Market Leaders
  • bioMeriux, Inc.
  • Bio-rad Laboratories, Inc.
  • Abbott Laboratories
  • Hoffmann La Roche Ltd.
  • Qiagen N.V.
  • Becton, Dickinson and Company
  • Myriad Genetics, Inc.
Nucleic Acid Testing Market

Drivers and Restraints

Increase in the R&D for the development of newer products is a major factor drive the global nucleic acid testing market over the forecast years. For instance, in June 2018, Grifols received FDA approval for two blood screening assays: Procleix Ultrio Elite and Procleix WNV. Procleix Ultrio Elite to detect HIV 1, Hepatitis C, Hepatitis B, and HIV 2 based on nucleic acid testing. Moreover, raise in funding for R&D also boost the market over the forecast timeframe. For instance, in 2016, The National Cancer Institute has reserved $3.9 Bn to fund the establishment of laboratories to advance research on assays for cancers of the breast, prostate, lung, and genitourinary organs.


Nucleic Acid Testing Market Regional Analysis

North America dominates the market

North America contributed largest share in 2018 with a share of approximately 42% due to increased incidence of certain types of cancers in USA and Canada. For instance, according to National Cancer Institute 2018, approximately 1,735,350 cases diagnosed with cancer in United States. Moreover, rise in R&D for the development of technologically advanced diagnostic methods and sophisticated healthcare infrastructure are bolster the market. Europe nucleic acid testing market contributed highest growth rate in 2018 and expected to grow at 6.3% CAGR over the forecast years owing to adoption of advanced technologies, surge in prevalence of infectious diseases, and favorable reimbursement policies in the region.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis
Nucleic Acid Testing Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

  • bioMeriux, Inc.
  • Bio-rad Laboratories, Inc.
  • Abbott Laboratories
  • Hoffmann La Roche Ltd.
  • Qiagen N.V.
  • Becton, Dickinson and Company
  • Myriad Genetics, Inc.
  • Quest Diagnostics
  • Hologic, Inc.
  • Grifols S.A.
  • Illumina, Inc.
  • Siemens AG
  • Gen-Probe
  • Danaher Corporation
  • Merck KGaA

Description

Nucleic acid testing market size was valued at USD x billion in 2021, growing at a CAGR of x% during the forecast period 2022-2028. Nucleic acid testing market report gives a comprehensive outlook on nucleic acid testing across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of product type, technology, application, end user, and region. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged.

Nucleic acid testing market is estimated to grow at significant CAGR over the forecast years 2022-2028 due to an increase in the prevalence of certain types of cancers and infectious diseases across the globe. For instance, according to WHO 2018 data, approximately 9.6 Mn death occurred due to cancer around the globe. Moreover, rise in R&D for the development of advanced technologies for nucleic acid testing, increased in demand for early stage disease diagnosis and personalized medicine, raise in funding from public and private sectors for the healthcare infrastructure development, and surge in demand for nucleic acid testing from blood banks are anticipated to boost the market over the forecast timeframe. However, stringent regulatory guidelines, high cost and complexity in the testing, and lack of skilled professionals and sophisticated healthcare infrastructure in underdeveloped countries are hinder the growth of market in future years.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX